Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-013856
Filing Date
2004-03-03
Accepted
2004-03-03 11:05:56
Documents
2
Period of Report
2001-08-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4873
3 POA DOCUMENT poa.txt EX-24.4_33919 3920
  Complete submission text file 0001209191-04-013856.txt   10657
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 8320 GUILFORD RD STE C COLUMBIA MD 21046
Business Address
LAZARUS J MICHAEL MD (Reporting) CIK: 0001219782 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 04644848